NCT06530251 2026-03-04A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)AkesoPhase 1/2 Recruiting280 enrolled
NCT07331883 2026-01-21Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)Ruijin HospitalPhase 2 Recruiting35 enrolled